We are live on ! Find out more
FIA

FNY Investment Advisers Portfolio holdings

AUM $278M
1-Year Est. Return 98.99%
This Fund
S&P 500
This Quarter Est. Return
+17.25%
1 Year Est. Return
+98.99%
3 Year Est. Return
+307.32%
5 Year Est. Return
+396.61%
10 Year Est. Return
–
AUM
$354M
AUM Growth
+$43.2M
Cap. Flow
+$30.3M
Cap. Flow %
8.54%
Top 10 Hldgs %
31.72%
Holding
1,674
New
354
Increased
213
Reduced
237
Closed
746

Top Buys

Rank Stock Value
1
CDTX
Cidara Therapeutics
CDTX
+$23.5M
2
BMO icon
Bank of Montreal
BMO
+$13.2M
3
MPWR icon
Monolithic Power Systems
MPWR
+$10.1M
4
SILJ icon
Amplify Junior Silver Miners ETF
SILJ
+$9.5M
5
COPX icon
Global X Copper Miners ETF NEW
COPX
+$8.61M

Top Sells

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$15.8M
2
SBSW icon
Sibanye-Stillwater
SBSW
+$4.39M
3
MSFT icon
Microsoft
MSFT
+$3.76M
4
SGML icon
Sigma Lithium
SGML
+$3.53M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$3.36M

Sector Composition

Rank Sector Weight
1 Healthcare 20.04%
2 Financials 17.75%
3 Technology 15.74%
4 Industrials 7.52%
5 Consumer Discretionary 5.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMPH icon
901
Amphastar Pharmaceuticals
AMPH
$850M
– –
-1,000
Closed -$26K
AMZN icon
902
CALL
Amazon
AMZN
$2.88T
– –
-34
Closed -$7K
ANEB
903
DELISTED
Anebulo Pharmaceuticals
ANEB
$0 ﹤0.01%
100
+5
+5% +$11
ANET icon
904
CALL
Arista Networks
ANET
$265B
– –
-7
Closed -$1K
ANET icon
905
Arista Networks
ANET
$265B
– –
-7,479
Closed -$1.09M
ANF icon
906
Abercrombie & Fitch
ANF
$4.99B
– –
-68
Closed -$5K
APA icon
907
APA Corp
APA
$14B
– –
-14
Closed –
BNBX
908
DELISTED
BNB PLUS CORP
BNBX
– –
-30,084
Closed -$116K
APO icon
909
Apollo Global Management
APO
$81.9B
– –
-1,000
Closed -$133K
APP icon
910
Applovin
APP
$102B
– –
-2,177
Closed -$1.37M
APTV icon
911
CALL
Aptiv
APTV
$10.1B
– –
-100
Closed -$8K
AQMS icon
912
Aqua Metals
AQMS
$9.56M
– –
-787
Closed -$5K
ARM icon
913
Arm
ARM
$290B
– –
-923
Closed -$130K
ARVN icon
914
Arvinas
ARVN
$580M
– –
-20,350
Closed -$173K
ASAN icon
915
Asana
ASAN
$2.07B
– –
-2,047
Closed -$27K
ASO icon
916
Academy Sports + Outdoors
ASO
$3.05B
– –
-14
Closed –
ASPN icon
917
Aspen Aerogels
ASPN
$510M
– –
-3,412
Closed -$17.6K
ATAI icon
918
AtaiBeckley Inc
ATAI
$2.68B
– –
-6,824
Closed -$36K
ATEC icon
919
Alphatec Holdings
ATEC
$1.49B
– –
-5,090
Closed -$74K
ATEX icon
920
Anterix
ATEX
$1.74B
– –
-1,500
Closed -$32K
AMCI
921
AMC Robotics
AMCI
$104M
– –
-100
Closed -$1K
FRMM
922
Forum Markets
FRMM
$81.8M
– –
-11,667
Closed -$281K
AVDX
923
DELISTED
AvidXchange
AVDX
– –
-180
Closed -$1K
AVTR icon
924
Avantor
AVTR
$9.42B
– –
-5,365
Closed -$66K
AXGN icon
925
Axogen
AXGN
$2.67B
– –
-3,600
Closed -$64K
35 36
37
38 39

Similar funds

ACP
Arcus Capital Partners Atlanta, Georgia $278M AUM 14.53% 1-Year Est. Return
KWM
Kanen Wealth Management Coconut Creek, Florida $278M AUM 38.85% 1-Year Est. Return
CC
Checkpoint Capital San Francisco, California $279M AUM 45.74% 1-Year Est. Return
SL
SOF Ltd George Town, Cayman Islands $279M AUM 6.12% 1-Year Est. Return
BCH
Berkshire Capital Holdings San Jose, California $277M AUM 190.28% 1-Year Est. Return
NCM
NCM Capital Management Ramsey, New Jersey $279M AUM 26.47% 1-Year Est. Return
RFA
Resurgent Financial Advisors Atlanta, Georgia $277M AUM 21.5% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return

FNY Investment Advisers's Q4 2025 Portfolio in Review

As of Q4 2025, FNY Investment Advisers held 1,674 positions worth $354M, up 14% from $311M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

FNY Investment Advisers deployed $30.3M of net new capital in Q4 2025, opening 354 new positions and adding to 213 existing holdings. Its largest new stake was Cidara Therapeutics: 145,533 shares worth $32.1M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 12% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Sibanye-Stillwater, an estimated $4.39M trimmed.

  • FNY Investment Advisers's largest Q4 2025 buy was Cidara Therapeutics: 145,533 shares worth $32.1M.
  • FNY Investment Advisers added most to Morgan Stanley in Q4 2025, an estimated $6.17M increase.
  • FNY Investment Advisers's biggest Q4 2025 reduction was Sibanye-Stillwater, cutting an estimated $4.39M.
  • FNY Investment Advisers fully exited Verona Pharma in Q4 2025, selling an estimated $15.8M.
  • FNY Investment Advisers's ten largest holdings make up 32% of its $354M portfolio in Q4 2025.
  • FNY Investment Advisers opened 354 new positions and closed 746 in Q4 2025.
  • FNY Investment Advisers's portfolio value rose 14% quarter-over-quarter to $354M.

Based on FNY Investment Advisers's 13F filing for Q4 2025, filed 16 Jan 2026.